Acesso livre
Acesso livre

Infectologia

Casos globais de COVID-19 mostram queda substancial.

17 Set, 2021 | 12:37h

Global COVID-19 cases show substantial drop – CIDRAP

Perspectiva | Escolas começaram testagem em massa para COVID-19, mas obstáculos e incertezas permanecem.

17 Set, 2021 | 12:36h

Schools have begun mass testing for COVID-19. But hurdles and uncertainties remain – Science

Conteúdo relacionado: Cluster RCT: Daily contact testing of school-based contacts was non-inferior to self-isolation for control of COVID-19 transmission.

Perspectiva | Países com “COVID zero” poderão continuar mantendo o vírus sob controle?

17 Set, 2021 | 12:35h

Can ‘zero COVID’ countries continue to keep the virus at bay once they reopen? – Science

Guia para o tratamento de celulite e outras infecções de partes moles.

17 Set, 2021 | 12:19h

A guide to the Tx of cellulitis and other soft-tissue infections – Journal of Family Practice

Estudo randomizado por cluster | Teste diário dos contatos de pessoas infectadas foi não-inferior ao autoisolamento para controlar a transmissão da COVID-19 nas escolas.

17 Set, 2021 | 12:12h

Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial – The Lancet

Comentário convidado: Daily antigen testing to reduce disruption when schools return – The Lancet

Estudo randomizado | Rendesivir não melhora os desfechos em pacientes com COVID-19 admitidos em hospital.

17 Set, 2021 | 12:11h

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial – The Lancet Infectious Diseases

Comentário convidado: Remdesivir, on the road to DisCoVeRy – The Lancet Infectious Diseases

Conteúdos relacionados:

Systematic Review: “Remdesivir probably has little or no effect on all‐cause mortality at up to 28 days in hospitalized adults with SARS‐CoV‐2 infection. We are uncertain about the effects of remdesivir on clinical improvement and worsening”.

WHO Solidarity Trial: Remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19

Revisão | Prevenção da transmissão de hospedeiro para hospedeiro através das vacinas contra SARS-CoV-2.

17 Set, 2021 | 12:09h

Prevention of host-to-host transmission by SARS-CoV-2 vaccines – The Lancet Infectious Diseases

Conteúdos relacionados:

Study ties COVID vaccines to lower transmission rates.

Effect of Vaccination on Household Transmission of SARS-CoV-2 in England – “the likelihood of household transmission was approximately 40 to 50% lower in households of index patients who had been vaccinated 21 days or more before testing positive than in households of unvaccinated index patients”.

Study in England showed one dose of COVID-19 vaccine can cut household transmission by up to half – This protection is on top of the reduced risk of a vaccinated person developing symptomatic infection, which is around 60 to 65% after the first dose

Covid-19 vaccination prevents transmission from vaccinated to unvaccinated household members.

Ivermectina: revisão da Cochrane mais comentada de todos os tempos, até agora. Por quê?

17 Set, 2021 | 12:07h

Ivermectin: Cochrane’s most talked about review so far, ever. Why? – Cochrane Library

Revisão original: Systematic review: no evidence to support the use of Ivermectin for treating or preventing COVID-19.

 

Comentário no Twitter

 

Relatório do CDC mostra que pessoas não vacinadas são 11 vezes mais propensas a morrer de COVID-19.

17 Set, 2021 | 12:05h

Unvaccinated People Are 11 Times More Likely To Die Of COVID-19, New Research Finds – NPR

Estudo original: Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021 – CDC Morbidity and Mortality Weekly Report

 

Comentário no Twitter

 

A intrincada história das vacinas de mRNA.

17 Set, 2021 | 12:02h

The tangled history of mRNA vaccines – Nature

Conteúdos relacionados:

mRNA vaccines for infectious diseases: principles, delivery and clinical translation.

After COVID-19 successes, researchers push to develop mRNA vaccines for other infectious diseases and cancer.

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.